Objective. To document the occurrence of classical kernicterus in full
-term, otherwise healthy, breast-fed infants. Methods. Were viewed the
files of 22 cases referred to us by attorneys throughout the United S
tates during a period of 18 years, in which neonatal hyperbilirubinemi
a was alleged to be responsible for brain damage in apparently healthy
, nonimmunized, full-term infants. To qualify for inclusion, these inf
ants had to be born at 37 or more weeks' gestation, manifest the class
ic signs of acute bilirubin encephalopathy, and have the typical neuro
logic sequelae. Results. Six infants, born between 1979 and 1991, met
the criteria for inclusion. Their peak recorded bilirubin levels occur
red 4 to 10 days after birth and ranged from 39.0 to 49.7 mg/dL. All h
ad one or more exchange transfusions. One infant had an elevated retic
ulocyte count (9%) but no other evidence of hemolysis. The other infan
ts had no evidence of hemolysis, and no cause was found for the hyperb
ilirubinemia (other than breastfeeding). Conclusions. Although very ra
re, classic kernicterus can occur in apparently healthy, full-term, br
east-fed newborns who do not have hemolytic disease or any other disce
rnible cause for their jaundice. Such extreme elevations of bilirubin
are rare, and we do not know how often infants with similar serum bili
rubin levels escape harm. We also have no reliable method for identify
ing these infants early in the neonatal period. Closer follow-up after
birth and discharge from the hospital might have prevented some of th
ese outcomes, but rare, sporadic cases of kernicterus might not be pre
ventable unless we adopt an approach to follow-up and surveillance of
the newborn that is significantly more rigorous than has been practice
d. The feasibility, risks, costs, and benefits of this type of interve
ntion need to be determined.